HemaSphere
(Jun 2022)
P1658: DELAYED REVERSAL OF FACTOR V INHIBITOR ACTIVITY POST-IMMUNOSUPPRESSIVE THERAPY, FOLLOWED BY A SUCCESSFUL PREGNANCY: A CASE REPORT
- A. Cegledi,
- I. Bodo,
- J. Dolgos,
- A. Varkonyi,
- B. Vilimi,
- G. Mikala
Affiliations
- A. Cegledi
- 1 Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, National Institute of Hematology and Infectious Diseases
- I. Bodo
- 2 Department of Internal Medicine and Hematology, Semmeweis University, Budapest, Hungary
- J. Dolgos
- 1 Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, National Institute of Hematology and Infectious Diseases
- A. Varkonyi
- 1 Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, National Institute of Hematology and Infectious Diseases
- B. Vilimi
- 1 Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, National Institute of Hematology and Infectious Diseases
- G. Mikala
- 1 Department of Hematology and Stem Cell Transplantation, South Pest Central Hospital, National Institute of Hematology and Infectious Diseases
- DOI
-
https://doi.org/10.1097/01.HS9.0000849488.34758.87
- Journal volume & issue
-
Vol. 6
pp.
1539
– 1540
WeChat QR code